Innovation Drives the Future——Though the Journey is Long, Perseverance Leads to Success

Recently, Shanghai Lishan Biotech Co., Ltd. has received exciting news—it has officially been recognized as a National High-Tech Enterprise and has been awarded the "High-Tech Enterprise Certificate" jointly issued by the Shanghai Science and Technology Commission, the Shanghai Municipal Finance Bureau, and the Shanghai Municipal Office of the State Administration of Taxation. This recognition marks that Lishan Biotech has met the national standards for high-tech enterprises in areas such as innovative drug development, technological innovation, and achievement commercialization, serving as a strong endorsement of the company's sustained innovation capabilities and scientific research strength.

AI-Empowered: The Innovation Engine for Drug Discovery and Clinical Medicine

Lishan Biotech, as a high-tech enterprise focused on the global development of innovative drugs, has remained committed to major disease areas such as inflammation, oncology, and neurodegenerative disorders since its inception. Targeting unmet clinical needs, the company pursues a dual-engine strategy of AI-powered "Live Biotherapeutic Products (LBPs) + targeted small molecules." By leveraging the synergistic effects of modulating the microbial ecology and interfering with host pathways, the company breaks through traditional R&D bottlenecks, systematically expands the boundaries of microbiome-based therapeutics, and accelerates the discovery and commercialization of first-in-class drugs.

Building on this foundation, Lishan Biotech deeply integrates artificial intelligence with clinical medicine, employing a multimodal "knowledge + data" approach. This empowers patient clinical enrollment by significantly enhancing the precision of screening, effectively shortening enrollment timelines, and reducing clinical trial costs, thereby providing strong support for efficient translation from "bench to bedside."

Journey of Innovation: Honor is Recognition, and a New Beginning

Being recognized as a National High-Tech Enterprise is not only a strong affirmation of Lishan Biotech's unwavering commitment to innovation but also marks the beginning of a new journey. This era has bestowed upon us unique opportunities and entrusted us with a special mission. Standing at the forefront of biomedical technological advancement, the Lishan team will uphold our founding spirit of "For the livelihood of the people" staying committed and steadfast in our pursuit of continuous innovation, illuminating hope for life with the light of science.

Looking ahead, Lishan Biotech will accelerate the development of more globally groundbreaking therapeutic solutions and innovative drugs, contributing cutting-edge advancements to the cause of human health.